Plant polyphenols and tumors: From mechanisms to therapies, prevention, and protection against toxicity of anti-cancer treatments

Current Medicinal Chemistry

Volumn 16, Issue 30, 2009, Pages 3943-3965

  Korkina, L G ^a   De Luca, C ^a   Kostyuk, V A ^a   Pastore, S ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Chemoprevention; Chemotherapy; Cytoprotection; Cytotoxicity; Photoprotection; Phototoxicity; Plant polyphenols; Tumors

Indexed keywords

ANTINEOPLASTIC AGENT; APIGENIN; APTOCARPOL A; BAICALEIN; CAPSAICIN; CATECHIN; CURCUMIN; CYTOCHROME P450 1B1; DELPHINIDIN; DOXORUBICIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GENISTEIN; KAEMPFEROL; LIGNAN; LIPOXYGENASE; LUTEOLIN; POLYPHENOL; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN; PROSTAGLANDIN SYNTHASE; QUERCETIN; QUERCETIN VANADYL (IV) COMPLEX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SILIBININ; SILYMARIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANADYL DERIVATIVE;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOSYNTHESIS; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROTECTION; CELL TRANSFORMATION; CHELATION; CHEMOPROPHYLAXIS; CHEMOTHERAPY; CYTOSTASIS; CYTOTOXICITY; DIET THERAPY; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG POTENTIATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; METASTASIS INHIBITION; NEOPLASM; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PLANT; REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMOPREVENTION; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; PHENOLS; PLANT EXTRACTS;

EID: 70450182123     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789352312     Document Type: Review

References (297)

1. Hahlbrock, K.; Scheel, D. Physiology and molecular biology of phenylpropanoid metabolism. Ann. Rev. Plant Physiol. Plant Mol. Biol., 1989, 40, 347-369.
2. Ververidis, F.; Trantas, E.; Douglas, C.; Kretzchmar, G.; Panopoulos, N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I. Chemical diversity, impacts on plant biology and human health. Biotechnol. J., 2007, 2, 1214-1234. (Pubitemid 350047840)
3. Ververidis, F.; Trantas, E.; Douglas, C.; Kretzchmar, G.; Panopoulos, N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part II. Reconstruction in multienzyme pathways in plants and microbes. Biotechnol. J., 2007, 2, 1235-1249. (Pubitemid 350047841)
4. Korkina, L. Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health. Cell Mol. Biol., 2007, 53, 15-25. (Pubitemid 46799688)
5. Korkina, L.; Pastore, S.; De Luca, C.; Kostyuk, V. Metabolism of plant polyphenols in the skin: beneficial versus deleterious effects. Curr. Drug Metab., 2008, 9, 710-729.
6. Harborne, J.B. Nature, distribution, and function of plant flavonoids. In: Plant Flavonoids in Biology and Medicine, Cody, Middleton, Harborne, Eds.; Alan R. Liss: New York, 1986; pp. 15-24.
7. Harborne, J.B. The flavonoids: recent advances. In: Plant Pigments, Goodwin, Ed.; Academic Press: London, 1988; pp. 299-343.
8. Dewick, P.M. The Biosynthesis of shikimate metabolites. Nat. Prod. Rep., 1995, 12, 579-607.
9. Guillet, G.; De Luca, V. Wound-inducible biosynthesis of phytoalexin hydroxycinnamic acid amides of tyramine in tryptophan and tyrosine decarboxylase transgenic tobacco lines. Plant Physiol., 2005, 137, 692-699. (Pubitemid 43126697)
10. Hyodo, H.; Yang, S.F. Ethylene-enhanced synthesis of phenylalanin ammonia lyase in pea seedlings. Plant Physiol., 1971, 47, 765-770.
11. Dixon, R.A.; Paiva, N.L. Stress-induced phenylpropanoid metabolism. Plant Cell, 1995, 7, 1085-1097.
12. Richardson, P.M. Structure, biosynthesis, evolution, and physiological and ecological roles of plant flavonoids and related compounds important in chemoprevention. In Cancer Chemoprevention, Wattenberg, L., Lipkin, M., Boone, C.W. and. Kelloff, G.J., Eds.; FL CRC Press: Boca Raton, 1992; pp. 353-360.
13. Denisov, E.; Afanas'ev, I. Oxidation and Antioxidants in Organic Chemistry and Biology, CBC Taylor & Francis Group: Boca Raton-London- New York-Singapore, 2005.
14. Kuhnau, J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet, 1976, 24, 117-191.
15. Haslam, E. Practical Polyphenolics - From Structure to Molecular Recognition and Physiological Action, Cambridge University Press: Cambridge, UK, 1998; pp. 23-31.
16. Passos, CP.; Cardoso S.M.; Rosário, M.; Domingues, M.; Domingues, P; Silva, C.M.; Coimbra M.A. Evidence for galloylated type-A procyanidins in grape seeds. Food Chem., 2007, 105, 1457-1467.
17. Skibola, C.F.; Smith, M.T. Potential health impacts of excessive flavonoid intake. Free Rad. Biol. Med., 2000, 29, 375-383.
18. Meagher, L.P.; Spencer, P.; Lane, G.A.; Sivakumaran, S.; Fraser, K. What do Green Tea, Grapes Seeds, and Docks have in Common? Chemistry in New Zealand - New Zealand Institute of Chemistry, 2005, Sept., 6-9.
19. Kita, T.; Imai, S.; Sawada, H.; Kumagai, H.; Seto, H. The biosynthetic pathway of curcuminoid in turmeric (Curcuma longa) as revealed by 13C-labeled precursors. Biosci. Biotechnol. Biochem., 2008, 72, 1789-1798.
20. Aggarwal, B.B.; Sundaram, C.; Malani, N.; Ichikawa, H. Curcumin: the Indian solid gold. Adv. Exp. Med. Biol., 2007, 595, 1-75.
21. Hatcher, H.; Planalp, R.; Cho, J.; Torti, F.M.; Torti, S.V. Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci., 2008, 65, 1631-1652.
22. Aggarwal, B.B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 2006, 71, 1397-1421.
23. Choi, H.; Chun, Y.S.; Kim, S.W.; Kim, M.S.; Park, J.W. Curcumin inhibits hypoxia-inducible factor-1 degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol. Pharmacol., 2006, 70, 1664-1671.
24. Tomren, M.A.; Masson, M.; Loftsson, T.; Tonnesen, H.H. Studies on curcumin and curcuminoids: XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int. J. Pharm., 2007, 338, 27-34.
25. Langcake, P.; Pryce, R.J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol., 1976, 9, 77-86.
26. Saiko, P.; Szakmary, A.; Jaeger, W.; Szekeres, T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mut. Res., 2008, 658, 68-94.
27. Potter, G.A.; Patterson, L.H.; Wanogho, E.; Perry, P.J.; Butler, P.C.; Ijaz, T.; Ruparelia, K.C.; Lamb, J.H.; Farmer, P.B.; Stanley, L.A.; Burke, M.D. The cancer preventive agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer, 2002, 86, 774-778.
28. Smeds, A.I.; Eklund, P.C.; Sjoholm, R.E.; Willfor, S.M.; Nishibe, S.; Deyama, T.; Holmbom, B.R. Quantification of a broad spectrum of lignans in cereals, oilseeds, and nuts. J. Agric. Food Chem., 2007, 55, 1337-1346.
29. Russell, W.R.; Burkitt, M.J.; Scobbie, L.; Chesson, A. EPR investigation into the effects of substrate structure on peroxidase-catalyzed phenylpropanoid oxidation. Biomacromolecules, 2006, 7, 268-273. (Pubitemid 43154502)
30. Smeds, A.I.; Hakala, K.; Hurmerinta, T.T.; Kortela, L.; Saarinen, N.M.; Makela, S.I. Determination of plant and enterolignans in human serum by high-performance liquid chromatography with tandem mass spectrometric detection. J. Pharm. Biomed. Anal., 2006, 41, 898-905. (Pubitemid 44269075)
31. Jovanovic, S.V.; Steenken, S.; Simic, M.G.; Hara Y. In Flavonoids in Health and Disease, Rice-Evans and Packer, Eds.; Marcel Dekker, Inc.: New York, 1998; pp.137-161.
32. Bors, W.; Michel, C.; Schicora, S. Interaction of flavonoids with ascorbate and determination of their univalent redox potentials: A pulse radiolysis syudy. Free Rad. Biol. Med., 1995, 19, 45-52.
33. Pietta, P.G. Flavonoids as antioxidants. J. Nat. Prod., 2000, 63, 1035-1042.
34. Heim, K.E.; Tagliaferro, A.R.; Bobilya, D.J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem., 2002, 13, 572-584.
35. Stevenson, D.E.; Hurst, R.D. Polyphenolic phytochemicals - just antioxidants or much more? Cell Mol. Life Sci., 2007, 64, 2900-2916. (Pubitemid 351152245)
36. Khanna, D.; Sethi, G.; Ahn, K.S.; Pandey, M.K.; Kunnumakkara, A.B.; Sung, B.; Aggarwal, A.; Aggarwal, B.B. Natural products as a gold mine for arthritis treatment. Curr. Opin. Pharmacol., 2007, 7, 344-351.
37. Brambilla, D.; Mancuso, C.; Scuderi, M.R.; Bosco, P.; Cantarella, G.; Lempereur, L.; Di Benedetto, G.; Pezzino, S.; Bernardini, R. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile. Nutr. J., 2008, 7, 29.
38. Katiyar, S.K. UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett., 2007, 255, 1-11.
39. d'Ischia, M.; Panzella, L.; Manini, P.; Napolitano, A. The chemical basis of the antinitrosating action of polyphenolic cancer chemopreventive agents. Curr. Med. Chem., 2006, 13, 3133-3144.
40. Afanas'ev, I.B. Signaling functions of free radicals superoxide & nitric oxide under physiological & pathological conditions. Mol. Biotechnol., 2007, 37, 2-4.
41. Kostyuk, V.A.; Potapovitch, A.I. Superoxide-driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem. Int., 1989, 19, 1117-1124.
42. Laughton, M.J.; Halliwel, B.; Evans, P.J.; Hoult, J.R. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem. Pharmacol., 1989, 38, 2859-2865.
43. Roy, D.; Liehr, J.G. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. Increased superoxide formation by redox cycling of estrogen. J. Biol. Chem., 1988, 263, 3646-3651.
44. Galati, G.; Sabzevari, O.; Wilson, J.X.; O'Brien, P.J. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology, 2002, 177, 91-104.
45. Galati, G.; Moridani, M.Y.; Chan, T.S.; O'Brien, P.J. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Rad. Biol. Med., 2001, 30, 370-382.
46. Sakihama, Y.; Cohen, M.F.; Grace, S.C.; Yamasaki, H. Plant phenolic antioxidant and prooxidant activities: phenolics-induced oxidative damage mediated by metals in plants. Toxicology, 2002, 177, 67-80. (Pubitemid 34786245)
47. Kagan, V.E.; Tyurina, Y.Y. Recycling and redox cycling of phenolic antioxidants. Ann. N. Y. Acad. Sci., 1998, 854, 425-434.
48. Canada, A.T.; Giannella, E.; Nguyen, T.D.; Mason, R.P. The production of reactive oxygen species by dietary flavonols. Free Rad. Biol. Med., 1990, 9, 441-449. (Pubitemid 120037538)
49. Sahu, S.C.; Washington, M.C. Quercetin-induced lipid peroxidation and DNA damage in isolated rat-liver nuclei. Cancer Lett., 1991, 58, 75-79.
50. Akagawa, M.; Shigemitsu, T.; Suyama, K. Production of hydrogen peroxide by polyphenols and polyphenol-rich beverages under quasi-physiological conditions. Biosci. Biotechnol. Biochem., 2003, 67, 2632-2640. (Pubitemid 39251617)
51. Canada, A.T.; Watkins, W.D.; Nguyen, T.D. The toxicity of flavonoids to guinea pig enterocytes. Toxicol. Appl. Pharmacol., 1989, 99, 357-361.
52. Middleton, E.Jr.; Kandaswami, C.; Theoharides, T.C. The Effects of Plant Flavonoids on Mammalian Cells: Implications for Inflammation, Heart Disease, and Cancer. Pharmacol. Rev., 2000, 52, 673-1651
53. Fraga, C.G. Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life, 2007, 59, 308-315.
54. Osawa, T. Protective role of dietary polyphenols in oxidative stress. Mech. Ageing Dev., 1999, 111, 133-139.
55. Saladino, R.; Gualandi, G.; Farina, A.; Crestini, C.; Nencioni, L.; Palamara, A.T. Advances and challenges in the synthesis of highly oxidized natural phenols with antiviral, antioxidant and cytotoxic activities. Curr. Med. Chem., 2008, 15, 1500-1519.
56. Rossi, M.; Caruso, F.; Opazo, C.; Salciccioli, J. Crystal and molecular structure of piceatannol; scavenging features of resveratrol and piceatannol on hydroxyl and peroxyl radicals and docking with transthyretin. J. Agric. Food Chem., 2008, 56, 10557-10566.
57. Brown, J.E.; Khodr, H.; Hider, R.; Rice-Evans, C.A. Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties. Biochem. J., 1998, 330, 1173-1178. (Pubitemid 28161991) (Pubitemid 128705745)
58. Afanas'ev, I.B.; Dorozhko, A.I.; Brodskii, A.V.; Kostyuk, V.A.; Potapovich A.I. Chelating and Free Radical Scavenging Mechanisms of Inhibitory Action of Rutin and Quercetin in Lipid Peroxidation. Biochem. Pharmacol., 1989, 38, 1763-1769.
59. Kostyuk, V.A.; Potapovich, A.I. Antiradical and Chelating Effects in Flavonoid Protection against Silica-Induced Cell Injury. Arch. Biochem. Biophys., 1998, 355, 43-48.
60. Kuo, S.M.; Leavitt, P.S.; Lin, C.P. Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol. Trace Elem. Res., 1998, 62, 135-153.
61. van Acker, S. A. B. E.; van den Berg, D. J.; Tromp, M. N. J. L.; Griffoen, D. H.; van Bennekom, W. P.; van der Vijgh, W. J. F.; Bast, A. Structural aspects of antioxidant activity of flavonoids. Free Rad. Biol. Med., 1996, 20, 331-342. (Pubitemid 26077855)
62. Ren, J.; Meng, S.; Lekka, Ch.E.; Kaxiras, E. Complexation of flavonoids with iron: structure and optical signatures. J. Phys. Chem. B, 2008, 112, 1845-1850. (Pubitemid 351316389)
63. Guo, M.; Perez, C.; Wei, Y.; Rapoza, E.; Su, G.; Bou-Abdallah, F.; Chasteen, N.D. Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton Trans., 2007, 43, 4951-4961.
64. Halliwell, B., Gutteridge, J.M.C. Free Radicals in Biology and Medicine, University Press: Oxford, 1999.
65. Galey, J.B. Potential use of iron chelators against oxidative damage. Adv. Pharmacol., 1997, 38, 167-173.
66. Korkina, L.G.; Afanas'ev, I.B. Antioxidant and chelating properties of flavonoids. Adv. Pharmacol., 1997, 38, 151-163.
67. Kostyuk, V.A.; Potapovich, A.I.; Strigunova, E.N.; Kostyuk, T.V.; Afanas'ev I.B. Experimental evidence that flavonoids metal complexes may act as mimics of superoxide dismutase. Arch. Biochem. Biophys., 2004, 428, 204-208.
68. Kostyuk, V.; Potapovich, A.; Korkina, L. Plant polyphenol-metal complexes: effects on reactive oxygen species and cytoprotection against oxidative damage. Proc. European Meeting of the Society for Free Radical Research, October 10-13, 2007, Vilamoura, Algarve, Portugal, Monduzzi Ed. International Proceedings Division, Bologna (Italy), 2007; pp.131-135.
69. Kostyuk, V.A.; Potapovich, A.I.; Vladykovskaya, E.N.; Korkina, L.G.; Afanas'ev, I.B. Influence of metal ions on flavonoid protection against asbestos-induced cell injury. Arch. Biochem. Biophys., 2001, 385, 129-137.
70. Moridani, M.Y.; Pourahmad, J.; Bui, H.; Siraki, A.; O'Brien, P.J. Dietary flavonoid iron complexes as cytoprotective superoxide radical scavengers. Free Rad. Biol. Med., 2003, 34, 243-253.
71. De Souza, R.F.; De Giovani, W.F. Antioxidant properties of complexes of flavonoids with metal ions. Redox Rep., 2004, 9, 97-104. (Pubitemid 39022425)
72. Bukhari, S.B.; Memon, S.; Mahroof-Tahir, M.; Bhanger, M.I. Synthesis, characterization and antioxidant activity copper-quercetin complex. Spectrochim. Acta. A. Mol. Biomol. Spectrosc., 2008, 7, 1901-1906.
73. Gatz, S.A.; Wiesmuller, L. Take a break - resveratrol in action on DNA. Carcinogenesis, 2008, 29, 321-332. (Pubitemid 351359671)
74. Shamim, U.; Hanif, S.; Ullah, M.F.; Azmi, A.S.; Bhat, S.H.; Hadi, S.M. Plant polyphenols mobilize nuclear copper in human peripheral lymphocytes leading to oxidatively generated DNA breakage: implications for an anticancer mechanism. Free Rad. Res., 2008, 42, 764-772.
75. Hadi, S.M.; Showket, H.B.; Azmi, S.A.; Hanif, S.; Samim, U.; Ullah, M.F. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Cancer Biol., 2007, 17, 370-376.
76. Azmi, A.S.; Bhat, S.H.; Hanif, S.; Hadi, S.M. Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Lett., 2006, 580, 533-538. (Pubitemid 43089682)
77. Leist, M.; Jaattela, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol., 2001, 2, 589-598. (Pubitemid 33674010)
78. Yoshino, M.; Haneda, M.; Naruse, M.; Htay, H.H.; Tsuboushi, R.; Qiao, S.L.; Li, W.H.; Murakami, K.; Yokochi, T. Prooxidant activity of curcumin: copper-dependent formation of 8-hydroxy-2′-deoxyguanosine in DNA and induction of apoptotic cell death. Toxicol. In Vitro, 2004, 18, 783-788. (Pubitemid 39311889)
79. Noda, C.; He, J.; Takano, T.; Tanaka, C.; Kondo, T.; Tohyama, K.; Yamamura, H.; Tohyama, Y. Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells. Biochem. Biophys. Res. Commun., 2007, 362, 951-957. (Pubitemid 47390666)
80. Heiss, E.H.; Shilder, Y.D.C.; Dirsch, V.M. Chronic treatment with resveratrol induces redox stress- and ATM-dependent senescence in p53-positive cancer cells. J. Biol. Chem., 2007, 282, 26759-26766.
81. Schmalhausen, E.V.; Zhlobek, E.B.; Shalova, I.N.; Firuzi, O.; Saso, L.; Muronetz, V.I. Antioxidant and prooxidant effects of quercetin on glyceraldehyde-3-phosphate dehydrogenase. Food. Chem. Toxicol., 2007, 45, 1988-1993.
82. Jun, T.; Bochu, W.; Liancai, Z. Hydrolytic cleavage of DNA by quercetin manganese (II) complexes. Colloids Surf. B. Biointerfaces, 2007, 55, 149-152. (Pubitemid 46274244)
83. Jun, T.; Bochu, W.; Liancai, Z. Hydrolytic cleavage of DNA by quercetin zinc(II) complex. Bioorg. Med. Chem. Lett., 2007, 17, 1197-1199. (Pubitemid 46240862)
84. Ni, Y.; Du, S.; Kokot, S. Interaction between quercetin-copper (II) complex and DNA with the use of the Neutral Red dye fluorophor probe. Anal. Chim. Acta., 2006, 584, 19-27. (Pubitemid 46123176)
85. Ferrer, E.G.; Salinas, M.V.; Correa, M.J.; Naso, L.; Barrio, D.A.; Etcheverry, S.B.; Lezama, L.; Rojo, T.; Williams, P.A. Synthesis, characterization, antitumoral and osteogenic activities of quercetin vanadyl (IV) complexes. J. Biol. Inorg. Chem., 2006, 11, 791-801.
86. Richardson, D.R. Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer. Curr. Med. Chem., 2005, 12, 2711-2729.
87. Korkina, L.; Pastore, S. The role of redox regulation in the normal physiology and inflammatory diseases of skin. Frontiers in Biosciences, 2009, E1, 123-141.
88. Thannickal, V.J.; Fanburg, B.L. Reactive oxygen species in cell signalling. Am. J. Physiol. Lung Cell Mol. Physiol., 2000, 279, 1005-1028.
89. Brigelius-Flohe, R.; Banning, A.; Kny, M.; Bol, G.F. Redox events in interleukin-1 signaling. Arch. Biochem. Biophys., 2004, 423, 66-73.
90. Afanas'ev, I.B. On mechanism of superoxide signaling under physiological and pathophysiological conditions. Med. Hypothesis, 2005, 64, 127-129.
91. Kluth, D.; Banning, A.; Paur, I.; Blomhoff, R.; Brigelius-Flohe, R. Modulation of pregnane X receptor- and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic. Biol. Med., 2007, 42, 315-325. (Pubitemid 46038039)
92. Cabello, C.M.; Bair III, W.B.; Wondrak, G.T. Experimental therapeutics: targeting the redox Achilles heel of cancer. Curr. Opin. Invest. Drugs, 2007, 8, 1022-1037.
93. Borbulevych, O. Y.; Jankun, J.; Selman, S. H.; Skrzypczak-Jankun, E. Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 Å resolution. Proteins, 2004, 54, 13-19. (Pubitemid 38036911)
94. Santangelo, C.; Vari, R., Scazzocchio, B., Di Benedetto, R., Filesi, C., Masella, R. Polyphenols, intracellular signalling and inflammation. Ann. Ist. Super. Sanità, 2007, 43, 394-405.
95. Jiang, F.; Guo, N.; Dusting, G.J. Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3′,4′- dihydroxyflavonol in phagocytic and vascular cells. J. Pharmacol. Exp. Ther., 2008, 324, 261-269.
96. Varga, Z.; Ujhelyi, L.; Kiss, A.; Balla, J.; Czompa, A.; Antus, S. Effect of silibin on phorbol myristate acetate-induced protein kinase C translocation, NADPH oxidase activity and apoptosis in human neutrophils. Phytomedicine, 2004, 11, 206-212. (Pubitemid 38314063)
97. Grandvaux, N.; Elsen, S.; Vignais, P.V. Oxidant-dependent phosphorylation of p40phox in B lymphocytes. Biochem. Biophys. Res. Commun., 2001, 287, 1009-1016.
98. Muranaka, S.; Fujita, H.; Fujiwara, T.; Ogino, T.; Sato, E.F.; Akiyama, J.; Imada, I.; Inoue, M.; Utsumi, K. Mechanism and characteristics of stimuli-dependent ROS generation in undifferentiated HL-60 cells. Antiox. Redox Signal., 2005, 7, 1367-1376.
99. Pignatelli, P.; Di Santo, S.; Buchetti, B.; Sanguigni, V.; Brunelli, A.; Violi, F. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment. FASEB J., 2006, 20, 1082-1089. (Pubitemid 44943904)
100. Nishikawa, H.; Wakano, K.; Kitani, S. Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell. Biochem. Biophys. Res. Commun., 2007, 362, 504-509. (Pubitemid 47332438)
101. Ying, C.J.; Sun, X.F.; Zhang, S.L.; Zhang, X.P.; Mao, L.M.; Zuo, X.Z.; Yao, P. ROS-related enzyme expressions in endothelial cells regulated by tea polyphenols. Biomed. Environ. Sci., 2004, 17, 33-39. (Pubitemid 38638968)
102. Carluccio, M.A.; Ancora, M.A.; Massaro, M.; Carluccio, M.; Scoditti, E.; Distante, A.; Storelli, C.; De Caterina, R. Homocysteine induces VCAM-1 gene expression through MF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am. J. Physiol. Heart Circ. Physiol., 2007, 293, H2344-2354. (Pubitemid 47605880)
103. Chueh, P.J.; Wu, L.Y.; Morre, D.M.; Morre, D.J. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. Biofactors, 2004, 20, 235-249.
104. Morre, D.J.; Morre, D.M.; Sun, H.; Cooper, R.; Chang, J.; Janle, E.M. Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX). Pharmacol. Toxicol., 2003, 92, 234-241.
105. Yagiz, K.; Morre, D.J.; Morre, D.M. Transgenic mouse line overexpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype. J. Nutr. Biochem., 2006, 17, 750-759.
106. Choi, S.I.; Jeong, C.S.; Cho, S.Y.; Lee, Y.S. Mechanism of apoptosis induced by apigenin in HepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase. Arch. Pharm. Res., 2007, 30, 1328-1335.
107. Kuan, Y.H.; Lin, R.H.; Tsao, L.T.; Lin, C.N.; Wang, J.P. Artocarpol A stimulation of superoxide anion generation in neutrophils involved the activation of PLC, PKC and p38 mitogen-activated PK signaling pathways. Br. J. Pharmacol., 2005, 145, 460-468.
108. Chun, K.S.; Surh, Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol., 2004, 68, 1089-1100.
109. Subbaramaiah, K.; Chung, W.J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J.M.; Danneberg, A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 1998, 273, 21875-21882. (Pubitemid 28405365)
110. 2 production. Bioorg. Med. Chem. Lett., 2004, 14, 2105-2108.
111. Schneider, I.; Bucar, F. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase. Phytother. Res., 2005, 19, 81-102. (Pubitemid 40646410)
112. Schneider, I.; Bucar, F. Lipoxygenase inhibitors from natural plant sources. Part 2: medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists. Phytother. Res., 2005, 19, 263-272. (Pubitemid 41098116)
113. Laughton, M.J.; Evans, P.J.; Moroney, M.A.; Hoult, J.R.; Halliwell, B. Inhibition of mammalian 5-lipoxygenase and cyclooxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol., 1991, 42, 1673-1681.
114. Kim, H.P.; Son, K.H.; Chang, H.W; Kang, S.S. K. Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci., 2004, 96, 229-245. (Pubitemid 40013328)
115. Deschamps, J.D.; Kenyon, V.A.; Holman, T.R. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg. Med. Chem., 2006, 14, 4295-4301.
116. Tong, W. G.; Ding, X. Z.; Adrian, T. E. The mechanisms of lipoxygenase inhibitor induced apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun., 2002, 296, 942-948.
117. Schewe, T.; Kühn, H.; Sies H. Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase. J. Nutr., 2002, 132, 1825-1829. (Pubitemid 34742863)
118. Sadik, C.D.; Sies, H.; Schewe, T. Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action. Biochem. Pharmacol., 2003, 65, 773-781. (Pubitemid 36293694)
119. Pinto Mdel, C., Macias, P. Oxidation of dietary polyphenolics by hydroperoxidase activity of lipoxygenase. J. Agric. Food. Chem., 2005, 53, 9225-9230.
120. Zhang, D.D. Mechanistic studies of the Nrf2-Keap 1 signaling pathway. Drug Metab. Rev., 2006, 38, 769-789.
121. Kobayashi, M.; Yamamoto M. Nrf2-Keap 1 regulation of cellular defense mechanisms against electrophils and reactive oxygen species. Adv. Enzyme Regul., 2006, 46, 113-140. (Pubitemid 44301353)
122. Wang, X.J.; Sun, Z.; Villeneuve, N.F.; Zhang, S.; Zhao, F.; Li, Y.; Chen, W.; Yi, X.; Zheng, W.; Wondrak, G.T.; Wong, P.K.; Zhang, D.D. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis, 2008, 29, 1235-1243.
123. Manson, M.M.; Farmer, P.B.; Gescher, A.; Steward, W.P. Innovative agents in cancer prevention. Recent Results Cancer Res., 2005, 166, 257-275.
124. Naithani, R.; Huma, L.C.; Moriarty, R.M.; McCormick, D.L.; Mehta, R.G. Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials. Curr. Med. Chem., 2008, 15, 1044-1071.
125. Fimognari, C.; Lenzi, M.; Hrelia, P. Chemoprevention of cancer by isothiocyanates and anthocyanins: mechanisms of action and structure-activity relashionship. Curr. Med. Chem., 2008, 15, 440-447.
126. Lu, H.; Ouyang, W.; Huang, C. Inflammation, a key event in cancer development. Mol. Cancer Res., 2006, 4, 221-233.
127. Aggarwal, B.B.; Shishodia, S., Sandur, S.K., Pandey, M.K., Sethi, G. Inflammation and cancer: how hot is the link? Biochem. Pharmacol., 2006, 72, 1605-1621.
128. Karin, M.; Greten, F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol., 2005, 5, 749-759. (Pubitemid 41400849)
129. Yoon, J.H.; Baek, S.J. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med. J., 2005, 46, 585-596. (Pubitemid 41804732)
130. Lee, J.L.; Mukhtar, H.; Bickers, D.R.; Kopelovich, L.; Athar, M. Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol. Appl. Pharmacol., 2003, 192, 294-306. (Pubitemid 37311345)
131. Jiang, C.; Ting, A.T.; Seed, B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature, 1998, 391, 82-86. (Pubitemid 28079219)
132. Klaunig, J.E.; Babich M.A.; Baetcke, K.P.; Cook, J.C.; Corton, J.C.; David, R.M.; De Luca, J.G.; Lai, D.Y.; McKee, R.H.; Peters, J.M.; Roberts, R.A. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol., 2003, 33, 655-780. (Pubitemid 38037444)
133. Kim, S.; Shin, H.J.; Kim, S.Y.; Kim, J.H.; Lee, Y.S.; Kim, D.H.; Lee, M.O. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol. Cell. Endocrinol., 2004, 220, 51-58.
134. Rahman, I.; Biswas, S.K.; Kirkham, P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol., 2006, 72, 1439-1452. (Pubitemid 44666744)
135. Portugal, M.; Barak, V.; Ginsburg, I.; Kohen, R. Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations. Biomed. Pharmacother., 2007, 61, 412-422. (Pubitemid 47239346)
136. Saliou, C.; Kitazawa, M.; McLaughlin, L.; Yang, J.P.; Lodge, J.K.; Tetsuka, T.; Iwasaki, K.; Cillard, J.; Okamoto, T.; Packer, L. Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappaB in a human keratinocyte cell line. Free Rad. Biol. Med., 1999, 26, 174-183.
137. Adhami, V.M; Afaq, F.; Ahmad, N. Suppression of ultraviolet B exposure-mediated activation of NFkappaB in normal human keratinocytes by resveratrol. Neoplasia, 2003, 5, 74-82. (Pubitemid 36151060)
138. Afaq, F.; Mukhtar, H. Botanical antioxidants in the prevention of photocarcinogenesis and photoaging. Exp. Dermatol., 2006, 15, 678-684. (Pubitemid 44145238)
139. Afaq, F.; Adhami, V.M.; Ahmad, N.; Mukhtar, H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene, 2003, 22, 1035-1044. (Pubitemid 36313147)
140. Eferl R.; Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer, 2003, 3, 859-868.
141. Xanthoudakis, S.; Curran, T. Redox regulation of AP-1. In: Biological Reactive Intermediates; Snyder, Ed.; Plenum Press: New York, 1996, pp. 69-75.
142. Dalton, T.P.; Shertzer, H.G.; Puga, A. Regulation of gene expression by reactive oxygene. Annu. Rev. Pharmacol. Toxicol., 1999, 39, 67-101. (Pubitemid 29222552)
143. Pearson, G.; Robinson, F.; Beers Gibson, T.; Xu, B.E.; Karandikar, M.; Berman, K.; Cobb, M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev., 2001, 22, 153-170.
144. Balasubramanian, S.; Eckert, R.L. Keratinocyte proliferation, differentiation, and apoptosis. Differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol. Appl. Pharmacol., 2007, 224, 214-219.
145. Pastore, S.; Mascia, F.; Mariotti, F.; Dattilo, F.; Mariani, V.; Girolomoni, G. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J. Immunol., 2005, 174, 5047-5056. (Pubitemid 40504590) (Pubitemid 40504590)
146. Giovannini, G.; Scazzocchio, B.; Varì, R.; Santangelo, C.; D'Archivio, M.; Masella, R. Apoptosis in cancer and atherosclerosis: polyphenol activities. Ann. Ist. Super. Sanità, 2007, 43, 406-416.
147. Ramos, S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr. Biochem. 2007, 18, 427-442. (Pubitemid 46874924)
148. Manna, S.K.; Mukhopadhyay, A.; Aggarwal, B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappaB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol., 2000, 164, 6509-6519.
149. Katiyar, S.K.; Afaq, F.; Azizuddin, K.; Mukhtar, H. Inhibition of UVB-induced oxidative stress-mediated phosphorylationof mitogen-activated protein kinase signalling pathways in cultured human epidermal keratinocytes by gree tea polyphenol (-)-epigallocathechin-3-gallate. Toxicol. Appl. Pharmacol., 2001, 176, 110-117. (Pubitemid 33015861)
150. Long, L.H.; Clement, M.V.; Halliwell, B. Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used culture media. Biochem. Biophys. Res. Commun., 2000, 273, 50-53. (Pubitemid 30426861)
151. Sharma, V.; Joseph, C.; Ghosh, S.; Agarwal, A.; Mishra, M.K.; Sen, E. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol. Cancer Ther., 2007, 6, 2544-2553. (Pubitemid 47480420)
152. Chen, C.; Yu, R.; Owuor, E.D.; Kong, A.N. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res., 2000, 23, 605-612.
153. 2 production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis, 2000, 21, 2035-2039.
154. Sakagami, H.; Arakawa, H.; Maeda, M.; Satoh, K.; Kadofuku, T.; Fukuchi, K.; Gomi, K. Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants. Anticancer Res., 2001, 21, 2633-2641. (Pubitemid 33054435)
155. Brusselmans, K.; De Shrijver, E.; Heyns, W.; Verhoeven, G.; Swinnen, J.V. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int. J. Cancer, 2003, 106, 856-862. (Pubitemid 37071663)
156. Shimizu, M.; Deguchi, A.; Lim, J.T.; Moriwaki, H.; Kopelovich, L.; Weinstein, IB. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res., 2005, 11, 2735-2746.
157. Chung, J.H.; Han, J.H.; Hwang, E.J.; Seo J.Y.; Cho, K.H.; Kim, K.H.; Youn, J.I.; Eun, H.C. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J., 2003, 17, 913-915.
158. Hou, Z.; Lambert, J.D.; Chin, K.-V.; Yang, C.S. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat. Res., 2004, 555, 3-19.
159. Chen, A.; Xu, J.; Johnson, A.C. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene, 2006, 25, 278-287.
160. Lambert, J.D.; Hong, J.; Yang, G.Y.; Liao, J.; Yang, C.S. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr., 2005, 81, 284S-291S.
161. Ahn, H.; Hadizadeh, K.; Seul, K.; Seul, C.; Yun, Y.P.; Vetter, H.; Sachinidis, A. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol. Biol. Cell., 1999, 10, 1093-1104. (Pubitemid 29193733)
162. Nicholson, K.; Anderson, N. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal., 2002, 14, 381-395. (Pubitemid 34214843)
163. Ballif, B.; Blenis, J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ., 2001, 12, 397-408. (Pubitemid 32762689)
164. Shaulian, E.; Karin, M. AP-1 in cell proliferation and survival. Oncogene, 2001, 20, 2390-2400.
165. Ramos, S. Cancer chemoprevention ad chemotherapy: dietary polyphenols and signalling pathways. Mol. Nutr. Food Res., 2008, 52, 507-526.
166. Perkins, N.; Gilmore, T. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ., 2006, 1, 1-14.
167. Yang, F.; Oz, H.S.; Barve, S.; de Villiers, W.; McClain, C.J.; Varilek, G.W. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol., 2001, 60, 528-533.
168. Shishodia, S.; Amin, H.M.; Lai, R.; Aggarwal, B.B. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol., 2005, 70, 700-713.
169. Gong, L.; Li, Y.; Nedeljkovic-Kurepa, A.; Sakar, F.H. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene, 2003, 22, 4702-4709.
170. Khan, N.; Afaq, F.; Mukhtar, H. Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis, 2007, 28, 233-239. (Pubitemid 46321838)
171. Yokoyama, M.; Noguchi, M.; Nakao, Y.; Pater, A.; Iwasaka, T. The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol. Oncol. 2004, 92, 197-204. (Pubitemid 38147391)
172. Hayakawa, S.; Saeki, K.; Sazuka, M.; Suzuki, Y.; Shoji, Y.; Ohta, T.; Kaji, K.; Yuo, A.; Isemura, M. Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem. Biophys. Res. Commun., 2001, 285, 1102-1106. (Pubitemid 32912894)
173. Shukla, Y. Tea and cancer chemoprevention: a comprehensive review. Asian Pacific J. Cancer Prev., 2007, 8, 155-166.
174. Chen, C.; Shen, G.; Hebbar, V.; Hu, R.; Owuor, E.D.; Kong, A.N. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis, 2003, 24, 1369-1378. (Pubitemid 37045317)
175. Hastak, K.; Gupta, S.; Ahmad, N.; Agarwal, M.L.; Mukhtar, H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene, 2003, 22, 4851-4859. (Pubitemid 36981273)
176. Nakazato, T.; Ito, K.; Ikeda, Y.; Kizaki, M. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin. Cancer Res., 2005, 11, 6040-6049. (Pubitemid 41170336)
177. Shankar, S.; Srivastava, R.K. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa. Carcinogenesis, 2007, 28, 1277-1286.
178. Lopez-Lazaro, M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res., 2008, 52, S103-S127.
179. Wang, H.; Mao, Y.; Chen, A.Y.; Zhou, N.; La Voie, E.J.; Liu, L.F. Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry, 2001, 40, 3316-3323.
180. Strick, R.; Strissel, P.L.; Borgers, S.; Smith, S.L.; Rowley, J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. USA, 2000, 97, 4790-4795.
181. Fang, J.; Lu, J.; Holmgren, A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J. Biol. Chem., 2005, 280, 25284-25290. (Pubitemid 40934623)
182. Tsvetkov, P.; Asher, G.; Reiss, V.; Shaul, Y.; Sachs, L.; Lotem, J. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc. Natl. Acad. Sci. USA, 2005, 102, 5535-5540. (Pubitemid 40530293)
183. Goel, A.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem. Pharmacol., 2008, 75, 787-809.
184. Boots, A.W.; Li, H.; Schins, R.P.; Duffin, R.; Heemskerk, J.W.; Bast, A.; Haenen, G.R. The quercetin paradox. Toxicol. Appl. Pharmacol., 2007, 222, 89-96.
185. Neto, C.C. Cranberry and its phytochemicals: a review of in vitro anticancer studies. J. Nutr. 2007, 137, 186S-193S.
186. Boots, A.W.; Haenen, G.R.M.M.; Bast, A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol., 2008, 585, 325-337.
187. Hanahan, D.; Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1999, 86, 353-364.
188. Karamysheva, A.F. Mechanisms of angiogenesis. Biochemistry (Moscow), 2008, 73, 751-762.
189. Bisacchi, D.; Benelli, R.; Vanzetto, C.; Ferrari, N.; Tosetti, F.; Albini, A. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect. Prev., 2003, 27, 229-238.
190. Westermarck, J.; Kahari, V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J., 1999, 13, 781-792. (Pubitemid 29220691)
191. Rabbani, S.; Xing, R.H. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int. J. Oncol., 1998, 12, 911-920.
192. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lancet, 2001, 357, 539-545.
193. Park, O.J.; Surh, Y.J. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol. Lett., 2004, 150, 43-56.
194. Mojzis, J.; Varinska, L.; Mojzisova, G.; Kostova, I.; Mirossay, L. Antiangiogenic effects of flavonoide and chalcones. Pharmacol. Rev., 2008, 57, 259-265.
195. Duthie, S.J. Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process. Mol. Nutr. Food Res., 2007, 51, 665-674.
196. Labrecque, L.; Lamy, S.; Chapus, A.; Mihoubi, S.; Durocher, Y.; Cass, B.; Bojanowski, M.W.; Gingras, D.; Beliveau, R. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis, 2005, 26, 821-826. (Pubitemid 41214345)
197. Kim, R.; Liu, L.; Guo, W.; Meydani, M. Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion. J. Nutr. Biochem., 2006, 17, 165-176. (Pubitemid 43247410)
198. Schindler, R.; Mentlein, R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J. Nutr., 2006, 136, 1477-1482. (Pubitemid 43765348)
199. Tan, W.F.; Lin, L.P.; Li, M.H.; Zhang, Y.X.; Tong, Y.G.; Xiao, D.; Ding, J. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur. J. Pharmacol., 2003, 459, 255-262.
200. Vijiababu, M.R.; Arunkumar, A.; Kanagaraj, P.; Venkataraman, P.; Krishnamoorty, G.; Arunakaran, J. Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol. Cell Biochem., 2006, 287, 109-116. (Pubitemid 44057398)
201. Annabi, B.; Lachambre, M.P.; Bousquet-Gagnon, N.; Page, M.; Gingras, D.; Beliveau, R. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim Biophys. Acta, 2002, 1542, 209-220. (Pubitemid 34165550)
202. Singh, R.P.; Dhanalakshmi, S.; Agarwal, C.; Agarwal, R. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy. Oncogene, 2005, 24, 1188-1202. (Pubitemid 40313920)
203. Piao, M.; Mori, M.; Satoh, T.; Sugita, Y.; Tokunaga, O. Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. Endothelium, 2006, 13, 249-266. (Pubitemid 44463534)
204. Oak, M.H.; Bedoui, J.F.; Madeira, S.V.; Chalupsky, K.; Schini-Kerth, V.B. Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br. J. Pharmacol., 2006, 149, 283-290.
205. Lamy, S.; Blanchette, M.; Michaud-Levesque, J.; Lafleur, R.; Durosher, Y., Moghrabi, A.; Gingras, D.; Beliveau, R. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis, 2006, 27, 989-996.
206. Zhang, Q.; Tang, X.; Zhang, Z.; Rao, J.; Le, A.D. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol. Cancer Ther., 2006, 5, 1227-1238.
207. Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, 4, 807-818.
208. Lambert, J.D.; Sang, S.; Lu, A.Y.H.; Yang, C.S. Metabolism of dietary polyphenols and possible interactions with drugs. Curr. Drug Metab., 2007, 8, 499-507. (Pubitemid 47603414)
209. Cermak, R. Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin. Drug Metab. Toxicol., 2008, 4, 17-35. (Pubitemid 351234098)
210. Pavek, P.; Dvorak, Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissue. Curr. Drug Metab., 2008, 9, 129-143.
211. Axelrod, J.; Tomchick, R. Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem., 1958, 233, 702-705.
212. Otake, Y.; Walle, T. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2 and CYP2C9. Drug Metab. Dispos., 2002, 30, 103-105. (Pubitemid 34106526)
213. Nielsen, S.E.; Breinholt, V.; Justesen, U.; Cornett, C.; Dragsted, L.O. In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica, 1998, 28, 389-401. (Pubitemid 28207043)
214. Vitaglione, P.; Donnarumma, G.; Napolitano, A.; Galvano, F.; Gallo, A.; Scalfi, L.; Fogliano, V. Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J. Nutr., 2007, 137, 2043-2048. (Pubitemid 47367263)
215. Lotito, S.B.; Frei, B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon? Free Rad. Biol. Med., 2006, 41, 1727-1746. (Pubitemid 44839139)
216. Janisch, K.M.; Williamson, G.; Needs, P.; Plumb, G.W. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Rad. Res., 2004, 38, 877-884.
217. Ahmad, N.; Mukhtar, H. Cytochrome P450: a target for drug development for skin diseases. J. Invest. Dermatol., 2004, 123, 417-425. (Pubitemid 39095608)
218. Chun, Y.J.; Ryu, S.Y.; Jeong, T.C.; Kim, M.Y. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metab. Dispos., 2001, 29, 389-393. (Pubitemid 32275551)
219. Chun, Y.J.; Kim, M.Y.; Guengerich, F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun., 1999, 262, 20-24.
220. Cavalieri, E.L.; Stack, D.E.; Devanesan, P.D.; Todorovich, R.; Dwivedy, I.; Higginbotham, S.; Johansson, S.L.; Patil, K.D.; Gross, M.L.; Gooden, J.K.; Ramanathan, R.; Cerny, R.L.; Rogan, E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 1997, 94, 10937-10942.
221. Chang, T.K.; Lee, W.B.; Ko, H.H. Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can. J. Physiol. Pharmacol., 2000, 78, 874-881. (Pubitemid 30951343)
222. Kim, S.; Ko, H.; Park, J.E.; Jung, S.; Lee, S.K.; Chun, Y.J. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J. Med. Chem., 2002, 45, 160-164.
223. Kris-Etherton, P.M.; Hecker, K.F.; Bonanome, A.; Coval, S.M.; Bincoski, A.E.; Hilpert, K.F.; Griel, A.E.; Etherton, T.D. Bioactive compounds in food: their role in the prevention of cardiovascular disease and cancer. Am. J. Med., 2002, 113 (Suppl. 9B), 71S-88S.
224. Kuiper, G.G.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; Saag, van der P.T.; Burg, van der B.; Gustaffson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 1998, 139, 4252-4363.
225. Maggiolini, M.; Bonofiglio, D.; Marsico, S.; Panno, M.L.; Cenni, B.; Picard, D.; Ando, S. Estrogen receptor a mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol., 2001, 60, 595-602. (Pubitemid 32782656)
226. Fang, H.; Tong, W.; Shi, M.; Blair, R.; Perkins, R.; Branham, W.; Hass, B.S.; Xie, Q.; Dial, S.L.; Moland, C.L.; Sheehan, D.M. Structure-activity relationships for a large diverse set of natural synthetic, and environmental estrogens. Chem. Res. Toxicol., 2001, 14, 280-294.
227. Gehm, B.D.; McAndrews, J.M.; Chien, P.Y.; Jameson, L.J. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist of the estrogen receptor. Proc. Natl. Acad. Sci. USA, 1997, 94, 14138-14143.
228. Gazak, R.; Walterova, D.; Kren, V. Silybin and silymarin - new and emerging applications in medicine. Curr. Med. Chem., 2007, 14, 315-338.
229. Papoutsi, Z.; Kassi, E.; Mitakou, S.; Aligiannis, N.; Tsiapara, A.; Chrousos, G.P.; Moutsatsou, P. Acteoside and martynoside exhibit estrogenic/antiestrogenic properties. J. Steroid Biochem. Mol. Biol., 2006, 98, 63-71.
230. Steiner, M.S.; Raghow, S. Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk. World J. Urol., 2003, 21, 31-36. (Pubitemid 44175294)
231. Saleem, M.; Kim, H.J.; Ali, M.S.; Lee, Y.S. An update on bioactive plant lignans. Nat. Prod. Rep. 2005, 22, 696-716.
232. Saarinen, N.M.; Warri, A.; Airio, M.; Smeds, A.; Makela, S. Role of dietary lignans in the reduction of breast cancer risk. Mol. Nutr. Food Res. 2007, 51, 857-866. (Pubitemid 47173695)
233. Lambert, J.D.; Sang, S.; Dougherty, A. ; Caldwell, C.G.; Meyers, R.O.; Dorr, R.T.; Timmermann, B.N. Cytotoxic lignans from Larrea tridentate. Phytochemistry, 2005, 66, 811-815.
234. Saarinen, N.M.; Penttinen, P.E.; Smeds, A.I.; Hurmerinta, T.T.; Makela, S.I. Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo. J. Steroid Biochem. Mol. Biol., 2005, 93, 209-219.
235. Saarinen, N.M.; Warri, A.; Dings, R.P.; Airio, M.; Smeds, A.I.; Makela, S.I. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. Int. J. Cancer, 2008, 123, 1196-1204.
236. Pajari, A.M.; Smeds, A.I.; Oikarinen, S.I.; Eklund, P.C.; Sjoholm, R.E.; Mutanen, M. The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation. Cancer Lett., 2006, 233, 309-314. (Pubitemid 43327387)
237. Minami, E.; Taki, M.; Takaishi, S.; Iijima, Y.; Tsutsumi, S.; Akiyama, T. Stereochemistry of cis- and trans-hinokiresinol and their estrogen-like activity. Chem. Pharm. Bull. (Tokyo), 2000, 48, 389-392. (Pubitemid 30187255)
238. Garg, A.K.; Buchholz, T.A.; Aggarwal, B.B. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal., 2005, 7, 1630-1647.
239. Yang, H.; Landis-Piwowar, K.R.; Chen, D.; Milacic, V; Dou, Q.P. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr. Protein Pept. Sci., 2008, 9, 227-239. (Pubitemid 351997839)
240. Menendez, J.A.; Vazquez-Martin, A.; Colomer, R.; Brunet, J.; Carrasco-Pancorbo, A.; Garcia-Villalba, R.; Fernandez-Gutierrez, A.; Segura-Carretero, A. Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer., 2007, 7, 80 (doi: 10.1186/1471-2407-7-80). (Pubitemid 46864916)
241. Aggarwal, B.B.; Shishodia, S.; Takada, Y.; Banerjee, S.; Newman, R.A.; Bueso-Ramos, C.E.; Price, JE. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res., 2005, 11, 7490-7498.
242. Quan, F.; Pan, C.; Ma, Q.; Zhang, S.; Yan, L. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line. Biomed. Pharmacother., 2008, 62, 622-629.
243. Nam, S.; Smith, D.M.; Dou, Q.P. Ester bond containing tea polyphenols potently inhibit proteasome activity in vivo. J. Biol. Chem., 2001, 276, 13322-13330. (Pubitemid 37385264) (Pubitemid 33649407)
244. Landis-Piwowar, K.R.; Milacic, V.; Chen, D.; Yang, H.; Zhao, Y.; Chan, T.H.; Yan, B.; Dou, Q.P. The proteasome as a potential target for novel anticancer drugs and chemosensitizers. Drug. Resist. Updat., 2006, 9, 263-273. (Pubitemid 46357634)
245. Kunnumakkara, A.B.; Diagaradjane, P.; Guha, S.; Deorukhkar, A.; Shentu, S.; Aggarwal, B.B.; Krishnan, S. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin. Cancer Res., 2008, 14, 2128-2136. (Pubitemid 351551125)
246. Chendil, D.; Ranga, R.S.; Meigooni, D.; Sathishkumar, S.; Ahmed, M.M. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene, 2004, 23, 599-607.
247. Aravindan, N.; Madhusoodhanan, R.; Ahmad, S; Johnson, D; Herman, T.S. Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol. Ther., 2008, 7, 569-576.
248. Javvadi, P.; Segan, A.T.; Tuttle, S.W.; Koumenis, C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol. Pharmacol. 2008, 73, 1491-1501. (Pubitemid 351574839)
249. Kasten-Pisula, U.; Tastan, H.; Dikomey, E. Huge differences in cellular radiosensitivity due to only very small variations in double-strand break repair capacity. Int. J. Radiat. Biol., 2005, 81, 409-419. (Pubitemid 41657557)
250. Cabello, C.M.; Blair, W.B.III; Wondrak G.T. Experimental therapeutics: targeting the redox Achilles heel of cancer. Curr. Opin. Investig. Drugs, 2007, 8, 1022-1037.
251. Wilson, B.C.; Patterson, M.S. The physics, biophysics, and technology of photodynamic therapy. Phys. Med. Biol., 2008, 53, R61-R109.
252. Zuluaga, M.-F.; Lange, N. Combination of photodynamic therapy with anti-cancer agents. Curr. Med. Chem., 2008, 15, 1655-1673.
253. Rahimipour, S.; Litichever,-Cosolvsky, N.; Alaluf, M.; Freeman, D.; Ehrenberg, B; Weiner, L.; Mazur, Y.; Fridkin, M.; Koch, Y. Novel methyl heliantrones as photosensitizers: synthesis and biological evaluation. Photochem. Photobiol., 2005, 81, 250-258. (Pubitemid 40551500)
254. Foster, T.H.; Pearson, B.D.; Mitra, S.; Bigelow, C.E. Fluorescence anisotropy imaging reveals localization of meso-tetrahydroxyphenyl chlorin in the nuclear envelope. Photochem. Photobiol., 2005, 81, 1544-1547.
255. Wilson J.D.; Bigelow, C.E.; Calkins, D.J.; Foster, T.H. Light scattering from intact cells reports oxidative-stress-induced mitochondrial swelling. Biophys. J., 2005, 88, 2929-2938. (Pubitemid 40976157)
256. Parrish, J.A.; Fitzpatrick, T.B.; Tanenbaum, L.; Pathak, M.A. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N. Engl. J. Med., 1974, 291, 1207-1211.
257. Lysenko, E.P.; Melnikova, V.O.; Andina, E.S.; Wunderlich, S.; Pliquett, F.; Potapenko, A.Y. Effects of glutahione peroxidase and catalase on hemolysis and methemoglobin modifications induced by photooxidized psoralen. J. Photochem. Photobiol. B., 2000, 56, 187-195.
258. Melnikova V.O.; Bezdetnaya, L.N.; Bour, C.; Festor, E.; Gramain, M.P.; Merlin, J.L.; Potapenko, A.Ya.; Guillemin, F. Subcellular localization of met-tetra (hydroxyphenyl) chlorin in human tumor cells subjected to photodynamic treatment. J. Photochem. Photobiol. B., 1999, 49, 96-103. (Pubitemid 29267478)
259. Murase, J.E.; Lee, E.E.; Koo, J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int. J. Dermatol. 2005, 44, 1016-1021. (Pubitemid 43046120)
260. Momtaz, K.; Fitzpatrick, T.B. The benefits and risks of long-term PUVA photochemotherapy. Dermatol. Clin., 1998, 16, 227-234.
261. Tønnesen, H.H.; de Vries, H.; Karlsen, J.; Beijersbergen van Henegouwen, G. Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems. J. Pharm. Sci., 1987, 76, 371-373. (Pubitemid 17119898)
262. Dahl, T.A.; Bilski, P.; Reszka, K.J.; Chignell, C.F. Photocytotoxicity of curcumin. Photochem. Photobiol., 1994, 59, 290-294.
263. Park, K.; Lee, J.H. Photosensitizer effect of curcumin on UVB-irradiated HaCaT cells through activation of caspase pathways. Oncol. Rep., 2007, 17, 537-540.
264. Bruzell, E.M.; Morisbak, E.; Tønnesen, H.H. Studies on curcumin and curcuminoids. XXIX. Photoinduced cytotoxicity of curcumin in selected aqueous preparations. Photochem. Photobiol. Sci., 2005, 4, 523-530.
265. Koon, H.; Leung, A.W.; Yue, K.K.; Mak, N.K. Photodynamic effect of curcumin on NPC/CNE2 cells. J. Environ. Pathol. Toxicol. Oncol., 2006, 25, 205-215.
266. Seve, M.; Chimienti, F.; Devergnas, S.; Aouffen, M.; Douki, T.; Chantegrel, J.; Cadet, J.; Favier, A. Resveratrol enhances UVA-induced DNA damage in HaCaT human keratinocytes. Med. Chem., 2005, 1, 629-633.
267. Ali, S.M.; Olivo, M. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. Int. J. Oncol., 2002, 21, 531-540.
268. Schempp, C.M.; Simon-Haarhaus, B.; Termeer, C.C.; Simon, J.C. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett., 2001, 493, 26-30. (Pubitemid 32241170)
269. Kiesslich, T.; Krammer, B.; Plaetzer, K. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr. Med. Chem., 2006, 13, 2189-2204. (Pubitemid 44132609)
270. F'guyer, S.; Afaq, F.; Mukhtar, H. Photochemoprevention of skin cancer by botanical agents. Photodermatol. Photoimmunol. Photomed., 2003, 19, 56-72.
271. Comelli, M.C.; Mengs, U.; Schneider, C.; Prosdocimi, M. Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy. Integr. Cancer. Ther., 2007, 6, 120-129. (Pubitemid 46871849)
272. Wei, H.; Zhang, X.; Wang, Y.; Lebwohl, M. Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Lett., 2002, 185, 21-29. (Pubitemid 34876529)
273. Moore, J.O.; Wang, Y.; Stebbins, W.G.; Gao, D.; Zhou, X.; Phelps, R.; Lebwohl, M.; Wei, H. Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesis. Carcinogenesis, 2006, 27, 1627-1635. (Pubitemid 44288052)
274. Katiyar, S.K.; Afaq, F.; Peres, A; Mukhar, H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis, 2001, 22, 287-294.
275. Zhao, J.F.; Zhang, Y.J.; Jin, X.H.; Athar, M.; Santella, R.M.; Bickers, D.R.; Wang, Z.Y. Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin. Invest. Dermatol., 1999, 113, 1070-1075.
276. Ramasamy, K; Agarwal, R. Multitargeted therapy of cancer by silymarin. Cancer Lett., 2008, 269, 352-362.
277. Chlopcíková, S.; Psotová, J.; Miketová, P.; Simánek, V. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans. Phytother. Res., 2004, 18, 107-110. (Pubitemid 38380601)
278. Shyong, EQ; Lu, Y.; Lazinsky, A.; Saladi, R.N.; Phelps, R.G.; Austin, L.M.; Lebwohl, M.; Wei, H. Effects of the isoflavone 4′,5,7- trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage. Carcinogenesis, 2002, 23, 317-321. (Pubitemid 34224009)
279. Lavie, G.; Barliya, T.; Mandel, M.; Blank, M.; Ron, Y.; Orenstein, A.; Livnat, T.; Friedman, N.; Weiner, L.; Sheves, M.; Weinberger, D. "Competitive quenching": a mechanism by which perihydroxylated perylenequinone photosensitizers can prevent adverse phototoxic damage caused by verteporfin during photodynamic therapy. Photochem. Photobiol., 2007, 83, 1270-1277. (Pubitemid 47438532)
280. Weinberger, D.; Ron, Y.; Lusky, M.; Gaaton, D.; Orenstein, A.; Blank, M.; Mandel, M.; Livnat, T.; Barliya, T.; Lavie, G. Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT. Curr. Eye Res., 2005, 30, 269-277. (Pubitemid 40806648)
281. Bertelli, A.A.; Ferrara, F.; Diana, G.; Fulgenzi, A.; Corsi, M.; Ponti, W.; Ferrero, M.E.; Bertelli, A. Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity. Int. J. Tissue React., 1999, 21, 93-104.
282. Annabi, B.; Lee, Y.T.; Martel, C.; Pilorget, A.; Bahary, J.P.; Béliveau, R. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate. Cancer Biol. Ther., 2003, 2, 642-649.
283. Sevin, A; Oztaş, P.; Senen, D.; Han, U.; Karaman, C.; Tarimci N, Kartal M, Erdoǧan B. Effects of polyphenols on skin damage due to ultraviolet A rays: an experimental study on rats. J. Eur. Acad. Dermatol. Venereol., 2007, 21, 650-656. (Pubitemid 46916763)
284. Bickers, D.R.; Athar, M. Novel approaches to chemoprevention of skin cancer. J. Dermatol., 2000, 27, 691-695. (Pubitemid 32015640)
285. Pajonk, F.; Riedisser, A.; Henke, M.; McBride, W.H.; Fiebich, B. The effects of tea extracts on proinflammatory signaling. BMC Med., 2006, 4, 28-34. (Pubitemid 44942825)
286. Taguri, T.; Tanaka, T.; Kouno, I. Antimicrobial activity of 10 different plant polyphenols against bacteria causing airborne disease. Biol. Pharm. Bull., 2004, 27, 1965-1969. (Pubitemid 41701572)
287. Kulac, M.; Ciftci, I.H.; Karaca, S.; Cetinkaya, Z. Clinical importance of Demodex folliculorum in patients receiving phototherapy. Int. J. Dermatol., 2008, 47, 72-77.
288. Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. J. Ethnopharmacol., 1999, 68, 3-37. (Pubitemid 29502456)
289. Merchant, T.E.; Bosley, C.; Smith, J.; Baratti, P.; Pritchard, D.; Davis, T.; Li, C.; Xiong, X. A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat. Oncol., 2007, 2, 45-49.
290. Richardson, J.; Smith, J.E.; McIntyre, M.; Thomas, R.; Pilkington, K. Aloe vera for preventing radiation-induced skin reactions: a systematic literature review. Clin. Oncol. (R Coll Radiol)., 2005, 17, 478-484.
291. Heggie, S.; Bryant, G.P.; Tripcony, L.; Keller, J.; Rose, P.; Glendenning, M.; Heath, J. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs., 2002, 25, 442-451. (Pubitemid 35424054)
292. Ernst, E. Adverse effects of herbal drugs in dermatology. Br. J. Dermatol., 2000, 143, 923-929. (Pubitemid 30848083)
293. Yoshimura, M.; Watanabe, Y.; Kasai, K.; Yamakoshi, J.; Koga, T. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci. Biotechnol. Biochem., 2005, 69, 2368-2373. (Pubitemid 43004371)
294. Zhu, W.Y.; Gao, J. The Use of Botanical Extracts as Topical Skin-Lightening Agents for the Improvement of Skin Pigmentation Disorders. J. Invest. Dermatol. Symposium Proceed., 2008, 13, 20-24.
295. Bittner, S. When quinones meet amino acids: chemical, physical and biological consequences. Amino Acids, 2006, 30, 205-224. (Pubitemid 43724048)
296. Chan, W.H.; Wu, H.J. Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells. J. Cell. Biochem., 2004, 92, 200-212.
297. López-Lázaro, M. Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res., 2008, 52 Suppl 1, S103-S127.